Lab boost for precious anti-malaria drug

US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.

One of the revolutions in in recent decades has been the advent of artemisinin drugs, whose active ingredient comes from a traditional Chinese herb, Artemisia annua.

But weather can affect harvests of the plant, causing shortages and .

In a study published in Nature, a team led by Chris Paddon of Amyris Inc., a biotech firm based in Emeryville, California, reported on a way to ferment artemisinic acid—a precursor to artemisinin—from genetically-engineered baker's yeast.

Their technique derives 25 grammes of concentrate from a litre of artemisinic acid. A previous attempt, reported by a European team last year, made only 1.6 grammes per litre.

The artemisinic acid can then be converted to artemisin by a simple chemical process using oxygen as a catalyst.

"Because all intellectual property rights have been provided free of charge, this technology has the potential to increase provision of first-line antimalarial treatments to the developing world at a reduced average annual price," the researchers said.

In 2010 there were more than 200 million cases of malaria, and at least 655,000 deaths, according to the UN's .

More information: dx.doi.org/10.1038/nature12051

Journal information: Nature

(c) 2013 AFP

Citation: Lab boost for precious anti-malaria drug (2013, April 10) retrieved 28 March 2024 from https://medicalxpress.com/news/2013-04-lab-boost-precious-anti-malaria-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Anti-malaria drug synthesized with the help of oxygen and light

 shares

Feedback to editors